Sitagliptin 100mg

DRUG18 trials

Conditions

DiabetesDiabetes After Total PancreatectomyDiabetes MellitusDiabetes Mellitus, Type 2Genetics DiseaseGraft Vs Host DiseaseHeart FailureKetonemia

Phase 1

Doxycycline in Type II Diabetes

RecruitingNCT06329882

Mostafa BahaaDiabetes Mellitus, Type 2

Start: 2024-03-30End: 2026-04-20Target: 60Updated: 2025-04-04

Phase 2

A Study of GSK256073 in Subjects With Type 2 Diabetes Mellitus Who Are Being Treated With Metformin

CompletedNCT01376323

GlaxoSmithKlineDiabetes Mellitus, Type 2

Start: 2011-07-13End: 2012-09-17Updated: 2017-10-11

Sitagliptin for the Treatment of Grade 3-4 and Refractory Acute Graft-versus-host Disease

NCT04448587

Rabin Medical CenterGraft Vs Host Disease

Start: 2020-10-01End: 2021-12-31Target: 10Updated: 2021-02-02

Effect of Sitagliptin on Polycystic Ovarian Syndrome Patients

NCT05972928

Beni-Suef UniversityPolycystic Ovary Syndrome

Start: 2023-07-30End: 2023-10-30Target: 80Updated: 2023-08-02

Phase 3

Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo Over 76 Weeks in Patients With Type 2 Diabetes

CompletedNCT01289990

Boehringer IngelheimDiabetes Mellitus, Type 2

Start: 2011-02-28End: 2013-05-31Updated: 2014-07-15

Sitagliptin vs. Pioglitazone as add-on Treatments in Patients With Type 2 Diabetes Uncontrolled on the Full-dose Metformin Plus Sulfonylurea

CompletedNCT03125694

Tehran University of Medical SciencesUncontrolled Type 2 Diabetes Mellitus

Start: 2015-02-01End: 2017-04-01Updated: 2017-04-24

Effect of CPL-2009-0031 in the Treatment of Patients With Uncontrolled Type 2 Diabetes Mellitus

CompletedNCT04801199

Cadila PharnmaceuticalsUncontrolled Type 2 Diabetes Mellitus

Start: 2020-01-26End: 2021-02-11Updated: 2021-08-17

Phase 4

Efficacy and Safety of Lobeglitazone Versus Sitagliptin

NCT02480465

Chong Kun Dang PharmaceuticalDiabetes Mellitus, Type 2

Start: 2015-01-31End: 2017-03-31Target: 248Updated: 2015-07-08

The Effects of Neprilysin on Glucagon-like Peptide-1

CompletedNCT03717688

Nicolai Jacob Wewer AlbrechtsenDiabetes, Heart Failure

Start: 2018-05-17End: 2019-05-14Updated: 2019-07-08

Metabolic Responses of Dapagliflozin vs Sitagliptin in T2DM Patients Inadequately Controlled With Insulin Therapy

CompletedNCT03959501

The University of Hong KongKetonemia, Type 2 Diabetes

Start: 2017-08-16End: 2020-10-16Updated: 2021-04-29

Effects of Sitagliptin in Individuals With Genetically Decreased DPP4

Active, not recruitingNCT04323189

University of PennsylvaniaGenetics Disease, Heart Failure, Type2 Diabetes

Start: 2020-08-26End: 2026-02-28Target: 20Updated: 2026-01-16

Sitagliptin for the Treatment of Type 2 Diabetes

NCT04495881

Beijing Chao Yang HospitalType 2 Diabetes

Start: 2020-01-01End: 2025-09-01Target: 50Updated: 2023-07-28

Safety and Efficacy of Antidiabetic Drugs in Recently Diagnosed Patients With Type 2 Diabetes

CompletedNCT04916093

Beni-Suef UniversityDiabetes Mellitus, Type 2

Start: 2019-12-20End: 2020-12-15Updated: 2021-06-07

Semaglutide vs Sitagliptin

NCT05195944

University Health Network, TorontoDiabetes Mellitus, Liver Transplant; Complications, NAFLD +1

Start: 2022-10-26End: 2024-12-31Target: 140Updated: 2022-11-08

SITAgliptin Plus GLARgine to Glycemic Control in the Hospital Setting (SITAGLAR-H)

CompletedNCT05579119

Hospital de Especialidades, Centro Medico Nacional La Raza, Instituto Mexicano del Seguro SocialType 2 Diabetes

Start: 2022-07-06End: 2023-08-24Updated: 2023-09-26

Unknown Phase

Involvement of Dipeptidyl Peptidase-4 and Sodium-glucose Co-transporter-2 in Extrapancreatic Glucagon Secretion

CompletedNCT04061473

University Hospital, Gentofte, CopenhagenDiabetes After Total Pancreatectomy

Start: 2019-04-02End: 2019-08-20Updated: 2019-09-04

Effect of Dapagliflozin vs Sitagliptin on Liver Fat Accumulation and Body Composition in Patients With Diabetes Mellitus and Liver Transplantation

CompletedNCT05042505

Medanta, The Medicity, IndiaDiabetes Mellitus, Liver Transplant; Complications

Start: 2022-01-01End: 2026-02-27Updated: 2026-03-03

Efficay and Safety of Empagliflozin Versus Sitagliptin for the In-patient Management of Hyperglycemia

CompletedNCT06187285

Medanta, The Medicity, IndiaType 2 Diabetes

Start: 2024-01-01End: 2025-06-01Updated: 2025-06-13

2024-04-031 citations

Regulation of Adropin by Sitagliptin monotherapy in participants with newly diagnosed type 2 Diabetes

BMC Endocrine Disorders2022-12-078 citations

Circulating Concentrations of C-Type Natriuretic Peptides Increase with Sacubitril/Valsartan Treatment in Healthy Young Men

Clinical Chemistry2022-01-1710 citations

Effect of Sitagliptin on Serum Irisin Levels in Patients with Newly Diagnosed Type 2 Diabetes Mellitus.

2021-02-2410 citations

Efficacy and safety of empagliflozin in Japanese patients with type 2 diabetes mellitus: A sub-analysis by body mass index and age of pooled data from three clinical trials

Diabetes Research and Clinical Practice2017-07-0817 citations

Safety, tolerability and effects on cardiometabolic risk factors of empagliflozin monotherapy in drug-naïve patients with type 2 diabetes: a double-blind extension of a Phase III randomized controlled trial

Cardiovascular Diabetology2015-12-01131 citations

Empagliflozin as add-on to metformin plus sulphonylurea in patients with type 2 diabetes.

2015-05-2962 citations